FDA Approves Botox Competitor That Lasts Longer

FRIDAY, Sept. 9, 2022 -- People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades. Daxxify, made by Revance Therapeutics Inc. in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news